Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ROIV |
---|---|---|
09:32 ET | 204315 | 11.94 |
09:34 ET | 13912 | 12 |
09:36 ET | 66844 | 11.95 |
09:38 ET | 9030 | 11.9405 |
09:39 ET | 14974 | 11.945 |
09:41 ET | 22264 | 11.96 |
09:43 ET | 21607 | 11.96 |
09:45 ET | 56083 | 11.935 |
09:48 ET | 13859 | 11.895 |
09:50 ET | 14395 | 11.855 |
09:52 ET | 87259 | 11.875 |
09:54 ET | 42439 | 11.905 |
09:56 ET | 20524 | 11.855 |
09:57 ET | 3238 | 11.855 |
09:59 ET | 24620 | 11.82 |
10:01 ET | 44305 | 11.87 |
10:03 ET | 13967 | 11.83 |
10:06 ET | 18567 | 11.81 |
10:08 ET | 17353 | 11.8 |
10:10 ET | 12499 | 11.81 |
10:12 ET | 18051 | 11.805 |
10:14 ET | 9103 | 11.795 |
10:15 ET | 10554 | 11.795 |
10:17 ET | 28666 | 11.795 |
10:19 ET | 19396 | 11.825 |
10:21 ET | 28319 | 11.81 |
10:24 ET | 8479 | 11.835 |
10:26 ET | 47517 | 11.865 |
10:28 ET | 26765 | 11.865 |
10:30 ET | 16008 | 11.885 |
10:32 ET | 31877 | 11.88 |
10:33 ET | 22318 | 11.9 |
10:35 ET | 41269 | 11.935 |
10:37 ET | 5160 | 11.935 |
10:39 ET | 51743 | 11.92 |
10:42 ET | 5928 | 11.915 |
10:44 ET | 5583 | 11.905 |
10:46 ET | 12028 | 11.92 |
10:48 ET | 3987 | 11.91 |
10:50 ET | 21567 | 11.925 |
10:51 ET | 8615 | 11.92 |
10:53 ET | 14190 | 11.8909 |
10:55 ET | 11191 | 11.9 |
10:57 ET | 33586 | 11.925 |
11:00 ET | 60808 | 11.915 |
11:02 ET | 21130 | 11.89 |
11:04 ET | 7984 | 11.87 |
11:06 ET | 10990 | 11.89 |
11:08 ET | 7902 | 11.895 |
11:09 ET | 29156 | 11.905 |
11:11 ET | 5612 | 11.91 |
11:13 ET | 11531 | 11.905 |
11:15 ET | 14972 | 11.91 |
11:18 ET | 18152 | 11.9 |
11:20 ET | 30286 | 11.92 |
11:22 ET | 30763 | 11.945 |
11:24 ET | 36899 | 11.905 |
11:26 ET | 5394 | 11.905 |
11:27 ET | 10772 | 11.92 |
11:29 ET | 9533 | 11.93 |
11:31 ET | 18768 | 11.91 |
11:33 ET | 5649 | 11.905 |
11:36 ET | 4363 | 11.91 |
11:38 ET | 15803 | 11.905 |
11:40 ET | 4882 | 11.915 |
11:42 ET | 7215 | 11.925 |
11:44 ET | 24965 | 11.91 |
11:45 ET | 8642 | 11.905 |
11:47 ET | 7498 | 11.905 |
11:49 ET | 20957 | 11.93 |
11:51 ET | 15359 | 11.93 |
11:54 ET | 15779 | 11.91 |
11:56 ET | 2580 | 11.915 |
11:58 ET | 7238 | 11.925 |
12:00 ET | 10314 | 11.925 |
12:02 ET | 20869 | 11.93 |
12:03 ET | 9233 | 11.93 |
12:05 ET | 22923 | 11.935 |
12:07 ET | 11164 | 11.94 |
12:09 ET | 42726 | 11.955 |
12:12 ET | 6543 | 11.96 |
12:14 ET | 35457 | 11.955 |
12:16 ET | 5033 | 11.955 |
12:18 ET | 32874 | 11.975 |
12:20 ET | 80442 | 11.975 |
12:21 ET | 14178 | 11.99 |
12:23 ET | 119623 | 11.985 |
12:25 ET | 37464 | 12 |
12:27 ET | 24607 | 12 |
12:30 ET | 72660 | 11.975 |
12:32 ET | 19955 | 11.955 |
12:34 ET | 15649 | 11.965 |
12:36 ET | 2051 | 11.965 |
12:38 ET | 25324 | 11.98 |
12:39 ET | 23377 | 11.995 |
12:41 ET | 37449 | 12 |
12:43 ET | 7021 | 12 |
12:45 ET | 46658 | 11.97 |
12:48 ET | 5163 | 11.965 |
12:50 ET | 3700 | 11.965 |
12:52 ET | 33253 | 11.98 |
12:54 ET | 12523 | 11.985 |
12:56 ET | 24480 | 11.995 |
12:57 ET | 145748 | 11.975 |
12:59 ET | 12674 | 11.975 |
01:01 ET | 3101 | 11.971 |
01:03 ET | 145156 | 11.98 |
01:06 ET | 36714 | 11.99 |
01:08 ET | 57232 | 12 |
01:10 ET | 50655 | 12.01 |
01:12 ET | 73599 | 11.99 |
01:14 ET | 55842 | 12.005 |
01:15 ET | 22780 | 12.015 |
01:17 ET | 10517 | 12.02 |
01:19 ET | 23278 | 12.015 |
01:21 ET | 37721 | 12 |
01:24 ET | 56229 | 11.965 |
01:26 ET | 33720 | 11.95 |
01:28 ET | 22590 | 11.94 |
01:30 ET | 9380 | 11.93 |
01:32 ET | 5800 | 11.93 |
01:33 ET | 26059 | 11.96 |
01:35 ET | 14831 | 11.96 |
01:37 ET | 13060 | 11.97 |
01:39 ET | 10392 | 11.965 |
01:42 ET | 45149 | 11.935 |
01:44 ET | 12792 | 11.925 |
01:46 ET | 10505 | 11.9265 |
01:48 ET | 19647 | 11.9 |
01:50 ET | 40275 | 11.895 |
01:51 ET | 22783 | 11.91 |
01:53 ET | 17648 | 11.92 |
01:55 ET | 6506 | 11.915 |
01:57 ET | 78168 | 11.93 |
02:00 ET | 83141 | 11.945 |
02:02 ET | 13740 | 11.955 |
02:04 ET | 29978 | 11.95 |
02:06 ET | 39344 | 11.945 |
02:08 ET | 3137 | 11.94 |
02:09 ET | 3789 | 11.94 |
02:11 ET | 25575 | 11.95 |
02:13 ET | 9936 | 11.955 |
02:15 ET | 7130 | 11.955 |
02:18 ET | 35521 | 11.945 |
02:20 ET | 3433 | 11.945 |
02:22 ET | 16677 | 11.955 |
02:24 ET | 4994 | 11.95 |
02:26 ET | 8327 | 11.955 |
02:27 ET | 15008 | 11.96 |
02:29 ET | 16462 | 11.955 |
02:31 ET | 16949 | 11.9574 |
02:33 ET | 79189 | 11.97 |
02:36 ET | 84203 | 11.99 |
02:38 ET | 30158 | 11.995 |
02:40 ET | 112478 | 12.005 |
02:42 ET | 143430 | 11.99 |
02:44 ET | 144988 | 12.015 |
02:45 ET | 92370 | 12.015 |
02:47 ET | 28292 | 12 |
02:49 ET | 21235 | 12.01 |
02:51 ET | 199453 | 12.01 |
02:54 ET | 224372 | 12.0264 |
02:56 ET | 172533 | 12.03 |
02:58 ET | 11749 | 12.035 |
03:00 ET | 126252 | 12.025 |
03:02 ET | 13703 | 12.025 |
03:03 ET | 9354 | 12.025 |
03:05 ET | 20108 | 12.0295 |
03:07 ET | 106231 | 12.04 |
03:09 ET | 91664 | 12.02 |
03:12 ET | 11485 | 12.025 |
03:14 ET | 7779 | 12.025 |
03:16 ET | 22253 | 12.025 |
03:18 ET | 81282 | 12.005 |
03:20 ET | 86658 | 11.985 |
03:21 ET | 119551 | 12.005 |
03:23 ET | 146869 | 11.961 |
03:25 ET | 46454 | 11.945 |
03:27 ET | 82924 | 11.94 |
03:30 ET | 61254 | 11.955 |
03:32 ET | 98944 | 11.96 |
03:34 ET | 78256 | 11.975 |
03:36 ET | 73786 | 11.95 |
03:38 ET | 66416 | 11.96 |
03:39 ET | 58462 | 11.97 |
03:41 ET | 122339 | 11.96 |
03:43 ET | 66052 | 11.96 |
03:45 ET | 35410 | 11.96 |
03:48 ET | 255448 | 11.97 |
03:50 ET | 39708 | 11.975 |
03:52 ET | 296216 | 12.005 |
03:54 ET | 177351 | 12.005 |
03:56 ET | 386403 | 11.98 |
03:57 ET | 231176 | 11.96 |
03:59 ET | 22260133 | 11.97 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Roivant Sciences Ltd | 8.8B | 2.1x | --- |
Corcept Therapeutics Inc | 4.3B | 37.2x | +9.80% |
Ligand Pharmaceuticals Inc | 1.9B | 46.2x | -12.71% |
Harrow Inc | 1.6B | -47.4x | --- |
Ocular Therapeutix Inc | 1.4B | -8.2x | --- |
Immunocore Holdings PLC | 1.7B | -31.0x | --- |
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting the neonatal Fc receptor (FcRn) in development across several IgG-mediated autoimmune indications; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 for the treatment of dermatomyositis and non-infectious uveitis, in addition to other clinical-stage molecules. It advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its pipeline program also includes Mosliciguat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.8B |
---|---|
Revenue (TTM) | $158.3M |
Shares Outstanding | 739.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $5.57 |
Book Value | $7.40 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | 55.7 |
Price/Cash Flow (TTM) | 1.9x |
Operating Margin | 2,799.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.